Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMS III stroke trial
2009-017454-12Phase 3Terminated
- Sponsor
- University of Cincinnati
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by University of Cincinnati. Primary endpoints: Primary efficacy outcome, Primary safety outcome - mortality and 1 more. Started Nov 2010; status: terminated.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2009-017454-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017454-12.